search
Back to results

Uterine Cooling During Cesarean Delivery to Reduce Blood Loss and Incidence of Postpartum Hemorrhage

Primary Purpose

Postpartum Hemorrhage, Uterine Atony

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Uterine Cooling
Sponsored by
Baylor Research Institute
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Postpartum Hemorrhage focused on measuring postpartum hemorrhage, uterine atony, cesarean section, cesarean hysterectomy, acute blood loss anemia, uterotonics, obstetric hemorrhage, severe hemorrhage, blood transfusion, obstetric emergencies, obstetrics, massive hemorrhage, hemorrhage, uterine cooling

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Pregnant adult women of any gravidity, and gestational duration who present for cesarean section at Baylor University Medical Center in Dallas and who have given informed consent to be in the study.

Exclusion Criteria:

  • Women who refuse to be in the study, and women who are unable to consent due to emergent nature of the cesarean section will be excluded. Women who are unable to understand the nature of the study due to mental illness, mental retardation, medical condition, or other communication barrier will be excluded.
  • Inability to exteriorize the uterus during c-section.

Sites / Locations

  • Baylor University Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Control

Uterine Cooling

Arm Description

Normal cesarean technique.

Immediately following delivery of the fetus the uterus will be externalized in the usual fashion and the body of the uterus cephalad to the hysterotomy incision will be wrapped in sterile surgical towels saturated in sterile, iced normal saline. These towels will come from a sterile cooling pot set to 30 degrees Fahrenheit. Iced saline-soaked towels will be kept in place for a minimum of 5 minutes and replaced at the discretion of the attending obstetrician until the hysterotomy is closed and the uterus is replaced into the patient's abdomen.

Outcomes

Primary Outcome Measures

Blood Loss
At the conclusion of the surgery, blood loss will be calculated by measuring the content of blood in the suction canister, and by weighing the surgical sponges. The amount of blood loss in the PACU will be measured by weighing pads.

Secondary Outcome Measures

Change in Pre- vs Post-operative Hematocrit
Use of Uterotonic Medications
Use of Extra Oxytocin
Use of Methergine
Use of Hemabate
Use of Cytotec
Bakri Bulb Placement
Use of Additional Measures to Control Blood Loss, Including Pharmacological and Surgical Interventions
Requirement of Blood Products
Total Blood Loss Greater Than 1000 cc
Requirement of Cesarean Hysterectomy

Full Information

First Posted
August 7, 2014
Last Updated
January 17, 2018
Sponsor
Baylor Research Institute
search

1. Study Identification

Unique Protocol Identification Number
NCT02229513
Brief Title
Uterine Cooling During Cesarean Delivery to Reduce Blood Loss and Incidence of Postpartum Hemorrhage
Official Title
Uterine Cooling During Cesarean Delivery to Reduce Blood Loss and Incidence of Postpartum Hemorrhage: A Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
December 2015
Overall Recruitment Status
Completed
Study Start Date
July 2013 (undefined)
Primary Completion Date
August 2014 (Actual)
Study Completion Date
August 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Baylor Research Institute

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The objective of the study is to demonstrate whether cooling the uterine smooth muscle during cesarean section (following delivery of the fetus) will promote better uterine contraction and involution resulting in lower blood loss, use of fewer uterotonic medications, and fewer hysterectomies following cesarean section. The investigators suspect that it may.
Detailed Description
Study Design: Patients will be randomly assigned to either the study group or the control group. Patients may receive regional (epidural or spinal/epidural) or general anesthesia.Initially, the investigators plan to enroll 200 subjects, 100 to the study group and 100 to the control group. Following delivery of the fetus, patients in the study group also will have Pitocin® administered to them according to the usual protocol.Immediately following delivery of the fetus the uterus will be externalized in the usual fashion and the body of the uterus cephalad to the hysterotomy incision will be wrapped in sterile surgical towels saturated in sterile, iced normal saline. These towels will come from a sterile cooling pot set to 30 degrees Fahrenheit. The skin of the abdomen will be draped to prevent contact with the cold towels. Additional uterotonic medications may be given at the discretion of the attending obstetrician. Iced saline-soaked towels will be kept in place for a minimum of 5 minutes and replaced at the discretion of the attending obstetrician until the hysterotomy is closed and the uterus is replaced into the patient's abdomen. The surface temperature of the uterus will be measured using an infrared thermometer prior to replacing the uterus into the abdomen. Two surgical suction canisters will be available. Immediately after delivery of the fetus and prior to delivery of the placenta, the amniotic fluid and blood on the surgical field will be aspirated into the first canister. The second suction canister will be used to aspirate blood and fluid until the conclusion of the operation. At the conclusion of the surgery blood loss will be calculated by measuring the content of blood in the second canister minus the amount of irrigation fluid used, and by weighing the surgical sponges. Average blood loss during cesarean sections has previously been reported as 500 to 1000 cc. The duration of cooling the uterus will be recorded. Use and amount of uterotonic medications also will be recorded. During the surgery the patient's vital signs will be monitored in the usual fashion. Particular attention will be paid to a change in her temperature. Warmed blankets and forced air warming blankets will be used to maintain normothermia, if required. At the conclusion of the study the amount of blood loss between the control and study groups, and the amount of uterotonic drugs will be calculated and compared. The number of patients in each group who require additional surgeries, e.g. hysterectomy or D&C, will be monitored. Pre-op and post-op hemograms will be compared if obtained at the discretion of the attending obstetrician. Blood product administration will be recorded. Determination of an ideal temperature of cooling towels is not an objective of the study. We're asking a qualitative question, not a quantitative question at this time. Study Rationale: The uterus is a smooth muscle whose contraction is modulated most directly by intrinsic or extrinsic oxytocin. During pregnancy the spiral arteries within the uterus and beneath the placenta enlarge to provide adequate perfusion to the placenta. After separation of the placenta the uterine smooth muscle cells contract in a pincer-like action to pinch the spiral arteries closed. When uterine contraction is inadequate (approximately 4-6% of normal pregnancies) the spiral arteries continue to bleed. If not addressed the bleeding can be excessive, even leading to maternal death. Approximately 5-8 out of 1,000 cesarean sections require hysterectomy to control bleeding. Release of calcium ions from sarcoplasmic reticulum stores is the immediate initiator of contraction, and calcium's diffusion from the muscle filaments and re-uptake by the sarcoplasmic reticulum results in relaxation of contraction. In some smooth muscles cold enhances contraction; perhaps by slowing the re-uptake of calcium. When the usual pharmacologic agents fail to induce adequate contraction of the uterine smooth muscle, the investigators suspect that application of cold may.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Postpartum Hemorrhage, Uterine Atony
Keywords
postpartum hemorrhage, uterine atony, cesarean section, cesarean hysterectomy, acute blood loss anemia, uterotonics, obstetric hemorrhage, severe hemorrhage, blood transfusion, obstetric emergencies, obstetrics, massive hemorrhage, hemorrhage, uterine cooling

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
200 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control
Arm Type
No Intervention
Arm Description
Normal cesarean technique.
Arm Title
Uterine Cooling
Arm Type
Experimental
Arm Description
Immediately following delivery of the fetus the uterus will be externalized in the usual fashion and the body of the uterus cephalad to the hysterotomy incision will be wrapped in sterile surgical towels saturated in sterile, iced normal saline. These towels will come from a sterile cooling pot set to 30 degrees Fahrenheit. Iced saline-soaked towels will be kept in place for a minimum of 5 minutes and replaced at the discretion of the attending obstetrician until the hysterotomy is closed and the uterus is replaced into the patient's abdomen.
Intervention Type
Procedure
Intervention Name(s)
Uterine Cooling
Other Intervention Name(s)
Hush Slush Machine
Intervention Description
Immediately following delivery of the fetus the uterus will be externalized in the usual fashion and the body of the uterus cephalad to the hysterotomy incision will be wrapped in sterile surgical towels saturated in sterile, iced normal saline. These towels will come from a sterile cooling pot set to 30 degrees Fahrenheit. Iced saline-soaked towels will be kept in place for a minimum of 5 minutes and replaced at the discretion of the attending obstetrician until the hysterotomy is closed and the uterus is replaced into the patient's abdomen.
Primary Outcome Measure Information:
Title
Blood Loss
Description
At the conclusion of the surgery, blood loss will be calculated by measuring the content of blood in the suction canister, and by weighing the surgical sponges. The amount of blood loss in the PACU will be measured by weighing pads.
Time Frame
During surgery and in the PACU (approximately 3 total hours)
Secondary Outcome Measure Information:
Title
Change in Pre- vs Post-operative Hematocrit
Time Frame
48 hours post operative period
Title
Use of Uterotonic Medications
Time Frame
During surgery and in the PACU (approximately 3 total hours)
Title
Use of Extra Oxytocin
Time Frame
Intraoperatively
Title
Use of Methergine
Time Frame
Intraoperatively
Title
Use of Hemabate
Time Frame
Intraoperatively
Title
Use of Cytotec
Time Frame
Intraoperatively
Title
Bakri Bulb Placement
Time Frame
Intraoperatively
Title
Use of Additional Measures to Control Blood Loss, Including Pharmacological and Surgical Interventions
Time Frame
Intraoperatively
Title
Requirement of Blood Products
Time Frame
During surgery and in the PACU (approximately 3 total hours)
Title
Total Blood Loss Greater Than 1000 cc
Time Frame
Intra-op, Post-Op
Title
Requirement of Cesarean Hysterectomy
Time Frame
During surgery and in the PACU (approximately 3 total hours)
Other Pre-specified Outcome Measures:
Title
Patient Temperature
Time Frame
Pre-op, Intra-op, Post-Op
Title
Total Time Uterus Wrapped
Time Frame
During hysterotomy repair
Title
Uterine Temperature After Wrap Removed
Time Frame
Immediately following hysterotomy repair

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Pregnant adult women of any gravidity, and gestational duration who present for cesarean section at Baylor University Medical Center in Dallas and who have given informed consent to be in the study. Exclusion Criteria: Women who refuse to be in the study, and women who are unable to consent due to emergent nature of the cesarean section will be excluded. Women who are unable to understand the nature of the study due to mental illness, mental retardation, medical condition, or other communication barrier will be excluded. Inability to exteriorize the uterus during c-section.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Janice L Mitchell, MD
Organizational Affiliation
Baylor University Medical Center Resident
Official's Role
Principal Investigator
Facility Information:
Facility Name
Baylor University Medical Center
City
Dallas
State/Province
Texas
ZIP/Postal Code
75246
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Uterine Cooling During Cesarean Delivery to Reduce Blood Loss and Incidence of Postpartum Hemorrhage

We'll reach out to this number within 24 hrs